Table 1

Characteristics of the patients with inflammatory bowel disease (IBD) and controls

Median age (range) (y)
 Male40.5 (20–77)36 (21–64)
 Female37 (17–69)35 (20–61)
Ulcerative colitis91
Crohn’s disease83
Duration of disease (range) (y)9.01 (0.3–40)
Receiving oral 5-ASA treatment144
 Sulphasalazine (Salazopyrin)40
 pH dependent release mesalazine (Asacol)8
 Slow release mesalazine (Pentasa)28
 Olsalazine (Dipentum)62
 Concurrent use of oral steroids13
 Concurrent use of azathioprine with/without steroids13
 Enema therapy only (5-ASA or steroid)6
 Receiving no maintenance therapy (5-ASA)18
History of intestinal resection18
 Terminal ileum or a part of small bowel6
Disease parameters—median (range)
 Haemoglobin (12–17 g/dl)12.5 (8.5–16.2)
 Platelet count (150–350 × 103/mm3)162 (158–678)
 Harvey Bradshaw index2 (0–11)
 Serum C-reactive protein3.27 (3.27–54.40)
  • 5-ASA, 5-aminosalicylic acid.